Pharyngeal colonization by streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage

Pediatric Infectious Disease Journal

Volumn 34, Issue 4, 2015, Pages 426-432

  Principi, Nicola ^a   Terranova, Leonardo ^a   Zampiero, Alberto ^a   Montinaro, Valentina ^a   Ierardi, Valentina ^a   Peves Rios, Walter ^a   Pelucchi, Claudio ^b   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

pneumococcal carrier; pneumococcal colonization; pneumococcal conjugate vaccine; pneumococcal vaccination; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; BACTERIAL DNA;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CHILD; DISEASE CARRIER; FEMALE; GROUPS BY AGE; HUMAN; INFLUENZA; ITALY; MALE; MENINGOCOCCOSIS; NONHUMAN; NORMAL HUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; CLASSIFICATION; GENETICS; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PREVENTION AND CONTROL; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPING; UTILIZATION;

ADOLESCENT; CARRIER STATE; CHILD; DNA, BACTERIAL; FEMALE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; REAL-TIME POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84937572789     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000637     Document Type: Article

References (31)

1. Auranen K, Rinta-Kokko H, Goldblatt D, et al. Pneumococcal Carriage Group (PneumoCarr). Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine. 2013;32:153-158.
2. Hammitt LL, Bruden DL, Butler JC, et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: An explanation of trends in invasive pneumococcal disease. J Infect Dis. 2006;193:1487-1494.
3. Myint TT, Madhava H, Balmer P, et al. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: A literature review. Adv Ther. 2013;30:127-151.
4. Weinberger DM, Bruden DT, Grant LR, et al. Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol. 2013;178:1488-1495.
5. Dagan R, Patterson S, Juergens C, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: A randomized double-blind trial. Clin Infect Dis. 2013;57:952-962.
6. Russell FM, Carapetis JR, Ketaiwai S, et al. Pneumococcal nasopharyngeal carriage and patterns of penicillin resistance in young children in Fiji. Ann Trop Paediatr. 2006;26:187-197.
7. Soewignjo S, Gessner BD, Sutanto A, et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin Infect Dis. 2001;32:1039-1043.
8. Hill PC, Akisanya A, Sankareh K, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis. 2006;43:673-679.
9. Rivera-Olivero IA, Bogaert D, Bello T, et al. Pneumococcal carriage among indigenous Warao children in Venezuela: serotypes, susceptibility patterns, and molecular epidemiology. Clin Infect Dis. 2007;45:1427-1434.
10. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4:e1000159.
11. Davis SM, Deloria-Knoll M, Kassa HT, et al. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32:133-145.
12. Ministero della Salute. Piano Nazionale Vaccini 2005-2007. Available at: http://www.salute.gov.it/portale/documentazione/p6-2-2-1.jsp?lingua= italiano&id=543. Accessed 6 May 2014.
13. Marchese A, Esposito S, Coppo E, et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-Time polymerase chain reaction using blood samples from Italian children =5 years of age with community-Acquired pneumonia. Microb Drug Resist. 2011;17:419-424.
14. Esposito S, Marchese A, Tozzi AE, et al. Italian Pneumococcal CAP Group. Bacteremic pneumococcal community-Acquired pneumonia in children less than 5 years of age in Italy. Pediatr Infect Dis J. 2012;31:705-710.
15. O'Brien KL, Nohynek H; World Health Organization Pneumococcal Vaccine Trials Carraige Working Group. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:133-140.
16. Principi N, Terranova L, Zampiero A, et al. Oropharyngeal and nasopharyngeal sampling for the detection of adolescent Streptococcus pneumoniae carriers. J Med Microbiol. 2014;63(Pt 3):393-398.
17. Trzcinski K, Bogaert D, Wyllie A, et al. Superiority of trans-oral over transnasal sampling in detecting Streptococcus pneumoniae colonization in adults. PLoS One. 2013;8:e60520.
18. Carvalho Mda G, Pimenta FC, Moura I, et al. Non-pneumococcal mitisgroup streptococci confound detection of pneumococcal capsular serotypespecific loci in upper respiratory tract. Peer J. 2013;1:e97.
19. Cvitkovic Spik V, Beovic B, Pokorn M, et al. Improvement of pneumococcal pneumonia diagnostics by the use of rt-PCR on plasma and respiratory samples. Scand J Infect Dis. 2013;45:731-737.
20. Dube FS, Kaba M, Whittaker E, et al. Detection of Streptococcus pneumoniae from Different Types of Nasopharyngeal Swabs in Children. PLoS One. 2013;8:e68097.
21. Hendley JO, Hayden FG, Winther B. Weekly point prevalence of Streptococcus pneumoniae, Hemophilus influenzae and Moraxella catarrhalis in the upper airways of normal young children: effect of respiratory illness and season. APMIS. 2005;113:213-220.
22. Le Polain de Waroux O, Flasche S, Prieto-Merino D, et al. Age-dependent prevalence of nasopharyngeal carriage of Streptococcus pneumoniae before conjugate vaccine introduction: A prediction model based on a meta-Analysis. PLoS One 2014; 9: e86136.
23. Zuccotti G, Mameli C, Daprai L, et al. PneuMi Study Group (PMSG). Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine. 2014;32:527-534.
24. Lakshman R, Murdoch C, Race G, et al. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child. 2003;88:211-214.
25. Pasinato A, Indolfi G, Marchisio P, et al. Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine. 2014;32:1375-1381.
26. Madhi SA, Adrian P, Kuwanda L, et al. Long-Term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization in HIV-Infected and HIV-uninfected children. J Infect Dis. 2007;196:1662-1666.
27. Millar EV, O'Brien KL, Bronsdon MA, et al. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1173-1179.
28. Dagan R, Givon-Lavi N, Fraser D, et al. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis. 2005;192:367-376.
29. Simell B, Nurkka A, Lahdenkari M, et al. Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol. 2012;19:96-99.
30. Grijalva CG, Griffin MR, Edwards KM, et al. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis. 2014;58:1369-1376.
31. Mitchell R, Truck J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6-17 years. Expert Opin Biol Ther. 2013;13:1451-1465.